Ignite Creation Date:
2024-05-06 @ 7:59 PM
Last Modification Date:
2024-10-26 @ 3:18 PM
Study NCT ID:
NCT06205641
Status:
RECRUITING
Last Update Posted:
2024-01-16
First Post:
2024-01-04
Brief Title:
A Prospective Multicenter Randomized Controlled Clinical Study on the Efficacy and Safety of Xuanfei Baidu Granule in the Treatment of Influenza A
Sponsor:
Capital Medical University
Organization:
Capital Medical University
Study Overview
Official Title:
A Prospective Multicenter Randomized Controlled Clinical Study on the Efficacy and Safety of Xuanfei Baidu Granule in the Treatment of Influenza A
Status:
RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is a prospective multicenter randomized controlled trial and aims to evaluate efficacy and safety of Xuanfei Baidu Granule in the treatment of influenza A
This study plans to enroll 584 subjects The subjects will be randomly divided into 4 groups according to the ratio of 1111 and they will be treated with Xuanfei Baidu Granule Placebo Xuanfei Baidu Granule Xuanfei Baidu Granule combined with Baloxavir Marboxil tablet1 bag of Xuanfei Baidu Granule and Xuanfei Baidu Granule Placebo in the morning and evening and take with boiling water for 5 days Baloxavir Marboxil Tablet was taken orally 2 tablets once a day for 1 day
The subjects were visited every day for 7 days after enrollment
This study plans to enroll 584 subjects The subjects will be randomly divided into 4 groups according to the ratio of 1111 and they will be treated with Xuanfei Baidu Granule Placebo Xuanfei Baidu Granule Xuanfei Baidu Granule combined with Baloxavir Marboxil tablet1 bag of Xuanfei Baidu Granule and Xuanfei Baidu Granule Placebo in the morning and evening and take with boiling water for 5 days Baloxavir Marboxil Tablet was taken orally 2 tablets once a day for 1 day
The subjects were visited every day for 7 days after enrollment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None